flumazenil has been researched along with Cerebral Arterial Diseases in 7 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Cerebral Arterial Diseases: Pathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Yamauchi, H | 3 |
| Kagawa, S | 3 |
| Kusano, K | 1 |
| Ito, M | 1 |
| Okuyama, C | 1 |
| Kishibe, Y | 1 |
| Takahashi, M | 1 |
| Higashi, T | 2 |
| Nishii, R | 1 |
| Fukuyama, H | 1 |
| Suzuki, T | 2 |
| Ogasawara, K | 2 |
| Kuroda, H | 2 |
| Chida, K | 2 |
| Aso, K | 2 |
| Kobayashi, M | 2 |
| Fujiwara, S | 2 |
| Yoshida, K | 2 |
| Terasaki, K | 2 |
| Ogawa, A | 2 |
| Kubo, Y | 1 |
| Makino, K | 1 |
| Kamiyama, H | 1 |
| Takamura, H | 1 |
| Gotoh, S | 1 |
| Kobayashi, N | 1 |
| Tsuchida, T | 1 |
| Yonekura, Y | 1 |
| Sadato, N | 1 |
| Takahashi, N | 1 |
| Yamamoto, K | 1 |
| Ishii, Y | 1 |
7 other studies available for flumazenil and Cerebral Arterial Diseases
| Article | Year |
|---|---|
Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A
Topics: Animals; Cerebral Arterial Diseases; Cerebral Infarction; Flumazenil; Humans; Oxygen; Positron-Emiss | 2022 |
Progressive Cortical Neuronal Damage and Chronic Hemodynamic Impairment in Atherosclerotic Major Cerebral Artery Disease.
Topics: Aged; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral Cortex; Cerebrovascular Circulat | 2016 |
Silent cortical neuronal damage in atherosclerotic disease of the major cerebral arteries.
Topics: Aged; Angiotensin Receptor Antagonists; Atherosclerosis; Carotid Artery, Internal; Cerebral Arterial | 2011 |
Comparison of early and late images on 123I-iomazenil SPECT with cerebral blood flow and oxygen extraction fraction images on PET in the cerebral cortex of patients with chronic unilateral major cerebral artery occlusive disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Carotid Artery, Internal; Cerebral Arterial Diseases; Cere | 2012 |
Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamid
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Area Under Curve; Arterial Occlusive Diseases; Carbon | 2012 |
Assessment of outcome by EC/IC bypass with 123I-iomazenil brain SPECT.
Topics: Aged; Arterial Occlusive Diseases; Brain; Carotid Artery, Internal; Carotid Stenosis; Cerebral Arter | 1999 |
Prediction of improvement of cerebral perfusion with I-123 iomazenil SPECT.
Topics: Arterial Occlusive Diseases; Brain; Carotid Artery, Internal; Carotid Stenosis; Cerebral Arterial Di | 1999 |